Allergan, Inc. (NYSE:AGN)

dollar sign

Top Q3 Equity Purchases and Sales of Top 50 Hedge Funds

It's no big secret that hedge funds had a rocky third quarter. However that did not stop them from adding certain equities to their holdings in hopes of boosting their returns. ...
Read Full Story »

2 Great Tech Stocks Added to UBS Quality Growth Portfolio

As we have reported at length lately, most of the top Wall Street firms that we cover are making some final year-end portfolio moves to try to help investors finish ...
Read Full Story »
Medicine pills

Why 2 Analysts Are Talking Up a Pfizer-Allergan Merger

The health care sector may have sold off a fair amount since this past summer, but there is some M&A action between giants in the sector that has potential to ...
Read Full Story »

6 BioPharma Movers That Cannot Be Ignored

Last week, a few biotech companies made absolutely massive runs, and some had serious falls. In the past year, the health care sector was on fire from positive trials, U.S. ...
Read Full Story »

What a Combined Allergan and Pfizer Might Actually Look Like

Allergan PLC (NYSE: AGN) has issued a press release that confirms some of the rumors floating in the market — it has been approached by Pfizer Inc. (NYSE: PFE) and ...
Read Full Story »
Pills and tablets

With Specialty Pharmaceuticals Down Big, 3 to Buy Now for Huge Potential Gains

It never fails. The guilt by association when something goes awry in a high-profile stock almost always bleeds to others, even if they have not a thing in common with ...
Read Full Story »
generic drugs

Generics Giants Like Teva and Mylan May Now Join the Buy-and-Raise Craze

Three weeks after Turing Pharmaceuticals CEO Martin Shkreli jacked up the price of niche toxoplasmosis drug Daraprim 55-fold after acquiring it from Impax Laboratories Inc. (NASDAQ: IPXL) many in the ...
Read Full Story »

Hot Political Rhetoric Hammers Specialty Pharmaceuticals: 3 to Buy Now

One tried and true tactic for politicians from both sides of the aisle is to go the populist route and blame society's ills on mean, greedy, big business. While it ...
Read Full Story »
generic drugs

UBS Makes Big Changes to Quality Growth at a Reasonable Price Portfolio

As we trudge through the dog days of August toward the traditional end-of-summer market slowdown, many of the firms we cover on Wall Street are making changes to their top ...
Read Full Story »
health care

What to Expect From Allergan Earnings

Allergan PLC (NYSE: AGN) is scheduled to report its second-quarter financial results Thursday before the markets open. The consensus estimates from Thomson Reuters call for $4.38 in earnings per share ...
Read Full Story »
buy sell

UBS Makes August Changes to Equity Focus List Portfolio

With the dog days of summer upon us, and the market starting to really slow down, some Wall Street firms are making the last changes for the third quarter recommendations ...
Read Full Story »
Biotechnology word cloud

3 Potential Huge Takeover Targets in Biotech

Usually when you think of a biotech takeover, it is a large cap biotech or pharmaceutical company that dives in and buys a small market cap stock with solid clinical ...
Read Full Story »

Teva Proves Its Decade-Hold Status With Massive Funding

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) may have just proved how financially fit and capable the company is. On Friday afternoon the global generic drug giant reported that it has ...
Read Full Story »

What Allergan Is Looking to Add With Kythera

The health care sector has been red hot over the past year, feeding numerous possibilities for mergers and acquisitions. Allergan PLC (NYSE: AGN) decided to strike while the iron was ...
Read Full Story »

American Airlines Replaces Allergan in S&P 500

American Airlines Group Inc. (NASDAQ: AAL) will be the newest addition to the S&P 500, taking the place of Allergan Inc. (NYSE: AGN). The change will occur after the close ...
Read Full Story »